Clinical Trial Update: A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Classroom Setting [Phase 3]

View source ↗

Summary

A pivotal Phase 3 efficacy trial evaluating HLD200 in children with ADHD has completed; results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• HLD200

Snippet

Sponsor: Ironshore Pharmaceuticals and Development, Inc | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED | Results posted: 2018-10-03